Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  RaySearch Laboratories AB (publ)    RAY B   SE0000135485


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

RaySearch Laboratories : RayStation in clinical use at both of Spain's proton centers

share with twitter share with LinkedIn share with facebook
08/28/2020 | 11:11am EDT

RaySearch Laboratories AB (publ) has announced that RayStation® is now in clinical use at the two proton centers currently established in Spain: Quirónsalud and Clínica Universidad de Navarra.

The two centers have invested in cutting-edge medical technology and software for proton therapy - an advanced, high-precision form of radiation therapy which is gaining ground as a treatment method for certain types of tumors. Both centers aim to give patients access to the best possible cancer care locally, thereby eliminating the need to travel abroad for proton therapy. They selected RayStation for its flexibility, accuracy and its wide range of tools. The treatment planning system offers groundbreaking features such as machine learning, multi-criteria optimization, ultrafast computation speed and support for adaptive radiation therapy.

Quirónsalud Hospital Group performed the country's first proton therapy treatments in December 2019 at its newly opened proton therapy center in Madrid. The facility is equipped with the Proteus®ONE* compact proton therapy system from IBA.

Clínica Universidad de Navarra began treating patients with proton therapy at its Madrid site in April 2020, creating the first proton therapy unit within a comprehensive cancer center in Spain. The facility is the first European installation of Hitachi's complete proton therapy system PROBEAT.

Juan María Pérez Moreno, PhD, medical physicist at Quirónsalud Proton Therapy Center, says: "Quironsalud is a cutting-edge facility that brings the benefits of highly precise PBS proton plans created with RayStation. Flexibility and a wide range of tools make RayStation a key element of our center. As a very dynamic system under continuous development and improvement, it will help us deliver optimal patient care in the future."

Felipe Calvo, director of the proton therapy unit at Clínica Universidad de Navarra, says: "Our facility enables patient treatments with higher precision. Combining RayStation with CT, MRI and PET scanning gives us outstanding accuracy both in targeting tumors and sparing healthy tissue."

Johan Löf, founder and CEO, RaySearch, says: "The efforts of medical professionals, supported by advances in technology, are making cancer treatments safer, more effective, and more personalized. Proton therapy is a key technique for the future, and we are very pleased to support these two pioneering centers with the latest advances in proton treatment planning. Together we are bringing the benefits of highly precise treatment to more patients in the country.

About Quirónsalud
Quirónsalud is the leading hospital group in Spain. Following a merger with Germany's Fresenius-Helios, it is now also the largest hospital group in Europe. Quirónsalud has over 60 years' experience in caring for people's health. Through first-class hospitals, world-renowned experts, cutting-edge medical technology, the highest safety standards and a strong commitment to quality, Quirónsalud provides each patient with unique and personalized care.

About Clínica Universidad de Navarra
Founded in 1962, Clínica Universidad de Navarra is a leading academic medical center recognized for its research and teaching work, skilled professionals and achievements in the treatment of highly complex pathologies. The center has developed a care model focused on the needs of patients and their families, which are at the center of its work and research. Clínica Universidad de Navarra has been ranked as a top private hospital in Spain, and among the 50 best hospitals in the world.

About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare*. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare. By harmonizing treatment planning, we enable better care for cancer patients worldwide.

* Subject to regulatory clearance in some markets.

More information about RaySearch is available at www.raysearchlabs.com

For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8510530 00

Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59




(c) 2020 Cision. All rights reserved., source Press Releases - English

share with twitter share with LinkedIn share with facebook
10/23RAYSEARCH LABORATORIES : will present further advances in machine learning and s..
09/16RAYSEARCH LABORATORIES : Cutting-edge cancer treatment comes to Belgium with the..
08/28RAYSEARCH LABORATORIES : RayStation in clinical use at both of Spain's proton ce..
08/26RAYSEARCH LABORATORIES : Interim report January 1 - June 30, 2020
07/15RAYSEARCH LABORATORIES PUBL : and TAE Life Sciences announce agreement on RaySta..
07/09RAYSEARCH LABORATORIES PUBL : Further clinical implementation of deep learning s..
06/30RAYSEARCH LABORATORIES PUBL : Bulletin from the Annual General Meeting 2020
06/29RAYSEARCH LABORATORIES PUBL : Machine learning algorithm from RaySearch enhances..
06/29RAYSEARCH LABORATORIES PUBL : Pioneering oncology information system RayCare 4A ..
06/24RAYSEARCH LABORATORIES PUBL : Axim Nuclear & Oncology to supply RaySearch system..
More news
Sales 2020 779 M 89,2 M 89,2 M
Net income 2020 66,5 M 7,62 M 7,62 M
Net cash 2020 15,0 M 1,72 M 1,72 M
P/E ratio 2020 39,5x
Yield 2020 0,39%
Capitalization 2 616 M 301 M 300 M
EV / Sales 2020 3,34x
EV / Sales 2021 2,83x
Nbr of Employees 396
Free-Float 69,7%
Duration : Period :
RaySearch Laboratories AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RAYSEARCH LABORATORIES AB (PUBL)
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 2
Average target price 93,50 SEK
Last Close Price 76,30 SEK
Spread / Highest target 24,5%
Spread / Average Target 22,5%
Spread / Lowest Target 20,6%
EPS Revisions
Johan Löf President, Chief Executive Officer & Director
Lars Micael Wollung Chairman
Peter Thysell Chief Financial Officer
Kjell Eriksson Chief Research Officer
Carl Filip Bergendal Director
Sector and Competitors
1st jan.Capitalization (M$)
VEEVA SYSTEMS INC.111.06%44 776
OMNICELL, INC.2.91%3 596
SECTRA AB (PUBL)45.65%2 510